Crabel Capital Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Crabel Capital Management’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-83,259	Closed	-$7.74M	–	156
2021 Q4	$7.74M	Buy	+83,259	New	+$5.49M	1.39%	23

Crabel Capital Management's ARNA Position: Q1 2022 in Review

Crabel Capital Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 83,259 shares — an estimated $7.74M sold.

Crabel Capital Management first reported a position in ARNA in Q4 2021 and held it in 1 quarter. The position peaked at $7.74M in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

Crabel Capital Management reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
Crabel Capital Management sold 83,259 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $7.74M.
Crabel Capital Management first reported a position in Arena Pharmaceuticals Inc in Q4 2021 and held it in 1 quarter.
Crabel Capital Management's Arena Pharmaceuticals Inc position peaked at $7.74M in Q4 2021.
1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Crabel Capital Management's 13F filing for Q1 2022, filed 6 May 2022.